Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
183.72
-2.46 (-1.32%)
At close: Feb 20, 2026, 4:00 PM EST
183.88
+0.16 (0.09%)
After-hours: Feb 20, 2026, 7:49 PM EST
Axsome Therapeutics Analyst Ratings
Total Analysts
17
Consensus Rating
Strong Buy
Price Target
$201.76
Upside
+9.82%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Strong Buy Maintains $200 → $245 | Strong Buy | Maintains | $200 → $245 | +33.36% | Feb 3, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $150 → $205 | Buy | Maintains | $150 → $205 | +11.58% | Jan 28, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $212 → $219 | Buy | Maintains | $212 → $219 | +19.20% | Jan 21, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $200 → $260 | Strong Buy | Maintains | $200 → $260 | +41.52% | Jan 20, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $148 → $223 | Buy | Maintains | $148 → $223 | +21.38% | Jan 16, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $157 → $193 | Buy | Maintains | $157 → $193 | +5.05% | Jan 13, 2026 |
| Morgan Stanley | Morgan Stanley | Buy → Hold Downgrades $196 → $204 | Buy → Hold | Downgrades | $196 → $204 | +11.04% | Jan 8, 2026 |
| UBS | UBS | Strong Buy Maintains $163 → $248 | Strong Buy | Maintains | $163 → $248 | +34.99% | Jan 6, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $185 → $200 | Strong Buy | Maintains | $185 → $200 | +8.86% | Jan 5, 2026 |
| Needham | Needham | Strong Buy Maintains $154 → $169 | Strong Buy | Maintains | $154 → $169 | -8.01% | Dec 31, 2025 |
| Mizuho | Mizuho | Buy Maintains $200 → $202 | Buy | Maintains | $200 → $202 | +9.95% | Nov 6, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $194 → $196 | Buy | Maintains | $194 → $196 | +6.68% | Nov 4, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $180 → $185 | Strong Buy | Maintains | $180 → $185 | +0.70% | Nov 4, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $189 → $198 | Buy | Maintains | $189 → $198 | +7.77% | Nov 4, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $163 → $157 | Buy | Maintains | $163 → $157 | -14.54% | Nov 4, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $200 → $205 | Strong Buy | Maintains | $200 → $205 | +11.58% | Nov 4, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.